Proof-of-concept Study of New Imaging Diagnostic in Patients With Suspected Alzheimer's Disease (clinicaltrials.gov) - Feb 16, 2024 - P1 | N=18 | Recruiting | Sponsor: Alzeca Biosciences, Inc. | Trial completion date: Jun 2024 ➔ Jan 2025 | Trial primary completion date: Jun 2024 ➔ Jan 2025
First-in-human • Trial completion date • Trial primary completion date • Alzheimer's Disease • CNS Disorders
|